The role of type I interferons (IFNs) in the regulation of chicken macrophage inflammatory response to bacterial challenge by Garrido, Damien et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The role of type I interferons (IFNs) in the regulation of chicken
macrophage inflammatory response to bacterial challenge
Citation for published version:
Garrido, D, Alber, A, Kut, E, Chanteloup, NK, Lion, A, Trotereau, A, Dupont, J, Tedin, K, Kaspers, B,
Vervelde, L, Trapp, S, Schouler, C & Guabiraba, R 2018, 'The role of type I interferons (IFNs) in the
regulation of chicken macrophage inflammatory response to bacterial challenge' Developmental and
Comparative Immunology, vol. 86, pp. 156-170. DOI: 10.1016/j.dci.2018.04.025
Digital Object Identifier (DOI):
10.1016/j.dci.2018.04.025
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Peer reviewed version
Published In:
Developmental and Comparative Immunology
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 09. May. 2019
Accepted Manuscript
The role of type I interferons (IFNs) in the regulation of chicken macrophage
inflammatory response to bacterial challenge
Damien Garrido, Andreas Alber, Emmanuel Kut, Nathalie K. Chanteloup, Adrien Lion,
Angélina Trotereau, Joëlle Dupont, Karsten Tedin, Bernd Kaspers, Lonneke Vervelde,
Sascha Trapp, Catherine Schouler, Rodrigo Guabiraba
PII: S0145-305X(18)30101-0
DOI: 10.1016/j.dci.2018.04.025
Reference: DCI 3161
To appear in: Developmental and Comparative Immunology
Received Date: 6 March 2018
Revised Date: 29 April 2018
Accepted Date: 29 April 2018
Please cite this article as: Garrido, D., Alber, A., Kut, E., Chanteloup, N.K., Lion, A., Trotereau, Angé.,
Dupont, Joë., Tedin, K., Kaspers, B., Vervelde, L., Trapp, S., Schouler, C., Guabiraba, R., The role of
type I interferons (IFNs) in the regulation of chicken macrophage inflammatory response to bacterial
challenge, Developmental and Comparative Immunology (2018), doi: 10.1016/j.dci.2018.04.025.
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to
our customers we are providing this early version of the manuscript. The manuscript will undergo
copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please
note that during the production process errors may be discovered which could affect the content, and all
legal disclaimers that apply to the journal pertain.
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
The role of type I interferons (IFNs) in the regulation of chicken 1 
macrophage inflammatory response to bacterial challenge 2 
 3 
Damien Garrido1, Andreas Alber2, Emmanuel Kut1, Nathalie K. Chanteloup1, Adrien Lion1, 4 
Angélina Trotereau1, Joëlle Dupont3, Karsten Tedin4, Bernd Kaspers5, Lonneke Vervelde2, 5 
Sascha Trapp1, Catherine Schouler1 & Rodrigo Guabiraba1* 6 
 7 
1ISP, INRA, Université de Tours, 37380, Nouzilly, France 8 
2The Roslin Institute and Royal (Dick) School of Veterinary Studies, University of 9 
Edinburgh, Midlothian, United Kingdom. 10 
3INRA, UMR85 Physiologie de la Reproduction et des Comportements, 37380, Nouzilly, 11 
France 12 
4Institute of Microbiology and Epizootics, Freie Universität Berlin, Germany. 13 
5Department of Veterinary Sciences, Institute for Animal Physiology, Ludwig-Maximilians-14 
University, Munich, Germany 15 
 16 
*Correspondence:  17 
Rodrigo Guabiraba, PhD. UMR 1282 Infectiologie et Santé Publique, Centre INRA Val de 18 
Loire. 37380, Nouzilly, France. Tel: +33 02 47 42 73 10. E-mail: rodrigo.guabiraba-19 
brito@inra.fr 20 
 
21 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Abstract 22 
Mammalian type I interferons (IFNα/β) are known to modulate inflammatory processes in 23 
addition to their antiviral properties. Indeed, virus-induced type I interferons regulate the 24 
mammalian phagocyte immune response to bacteria during superinfections. However, it 25 
remains unresolved whether type I IFNs similarly impact the chicken macrophage immune 26 
response. We first evidenced that IFNα and IFNβ act differently in terms of gene expression 27 
stimulation and activation of intracellular signaling pathways in chicken macrophages. Next, 28 
we showed that priming of chicken macrophages with IFNα increased bacteria uptake, 29 
boosted bacterial-induced ROS/NO production and led to an increased transcriptional 30 
expression or production of NOS2/NO, IL1B/IL-1β, and notably IFNB/IFNβ. Neutralization 31 
of IFNβ during bacterial challenge limited IFNα-induced augmentation of the pro-32 
inflammatory response. In conclusion, we demonstrated that type I IFNs differently regulate 33 
chicken macrophage functions and drive a pro-inflammatory response to bacterial challenge. 34 
These findings shed light on the diverse functions of type I IFNs in chicken macrophages. 35 
 36 
Keywords: Avian pathogenic E. coli; chicken; inflammation; interferon stimulated genes; 37 
macrophages; type I interferons   38 
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1. Introduction 39 
Interferons (IFNs) are key cytokines within the innate immune response. They were first 40 
discovered in 1957 due to their capacity to inhibit influenza virus replication in embryonated 41 
chicken eggs (Isaacs and Lindenmann, 1957). IFNs are divided into three subgroups: type I, 42 
II, and III IFNs. Type I IFNs, including various subtypes of IFNα, IFNβ, and some “minor” 43 
IFNs (i.e. IFNδ, IFNε, IFNκ, IFNτ, and IFNω), are produced during viral and bacterial 44 
infections (Bogdan et al., 2004; de Weerd and Nguyen, 2012; Ivashkiv and Donlin, 2014). In 45 
mammals, most cell types are able to produce IFNβ, including non-immune cells, while IFNα 46 
is mainly produced by hematopoietic cells, especially plasmacytoid dendritic cells (Ivashkiv 47 
and Donlin, 2014). IFNα and IFNβ bind to the same receptor, Interferon-alpha Receptor 48 
(IFNAR), which is composed of two subunits (IFNAR1 and IFNAR2) and expressed in the 49 
majority of tissues (de Weerd and Nguyen, 2012).  50 
 51 
Binding of type I IFNs to IFNAR entails the rapid activation of different signalling pathways 52 
for the regulation of Interferon-Stimulated Genes (ISGs) (Hervas-Stubbs et al., 2011), many 53 
of which play a critical role in the limitation of viral replication (Schneider et al., 2014). In 54 
addition, type I IFNs have been shown to enhance antigen-presentation, regulate 55 
inflammasome activation and upregulate pro-inflammatory cytokines production in 56 
mammalian species (Hervas-Stubbs et al., 2011; Malireddi and Kanneganti, 2013; Simmons 57 
et al., 2012). In humans, dysregulated type I IFNs responses were shown to be associated to 58 
immune disorders such as chronic infection, autoimmune and inflammatory diseases 59 
(Ivashkiv and Donlin, 2014; Trinchieri, 2010). Therefore, a tight regulation is required to 60 
shape the outcome of type I IFN responses in order to achieve the balance between IFN-61 
mediated protective immunity and exacerbated IFN signalling (Trinchieri, 2010).  62 
 63 
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Virus-induced type I IFNs have been associated to impaired host immune responses such as 64 
decreased bactericidal functions of phagocytic cells (Shepardson et al., 2016), granulocyte 65 
apoptosis (Merches et al., 2015; Navarini et al., 2006), over-activation of the Nod1/Nod2 66 
pathway (Kim et al., 2011), decreased chemokine secretion (Nakamura et al., 2011; 67 
Shahangian et al., 2009), and attenuation of antimicrobial peptides expression (Lee et al., 68 
2015). Consequently, certain cell populations such as macrophages may become affected by 69 
an enriched type I IFNs environment that is typical for viral infections (Shepardson et al., 70 
2016). These cellular and molecular events are at the origin of the well-established principle 71 
that primary viral infections may predispose the host to bacterial superinfections (McCullers, 72 
2014; Metzger and Sun, 2013). This observation is not restricted to humans and experimental 73 
mammalian models, since poultry species, including galliform birds, are often impacted by 74 
viral/bacterial co-infections (Ariaans et al., 2008; Gross, 1990; Kodihalli et al., 1994; Matthijs 75 
et al., 2009; Nakamura et al., 1994). However, cell populations and cytokines involved in the 76 
pathogenesis of co-infections affecting poultry are still poorly characterized.  77 
 78 
In galliform birds, viral infections such as those caused by low pathogenic avian influenza 79 
virus (LPAIV) may lead to a type I IFN response (Adams et al., 2009; Cornelissen et al., 80 
2012). However, it remains unclear whether this response contributes to predisposing animals 81 
to bacterial superinfection through a dysregulated macrophage function. Nevertheless, it is 82 
well established that macrophages play a key role during LPAIV infection and that they are 83 
efficiently responding to type I IFNs (Kodihalli et al., 1994; Qu et al., 2013). In turkeys, it has 84 
been demonstrated that LPAIV infection compromises pulmonary macrophages function, 85 
which would likely predispose birds to secondary bacterial infections (Kodihalli et al., 1994). 86 
These studies underscore the relevance of macrophages and their crucial role in the early 87 
phases of infection for the priming of an efficient antiviral host response to limit viral 88 
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dissemination (Abdul-Cader et al., 2017; Duan et al., 2017; Fujisawa et al., 1987). In addition, 89 
macrophages appear to have an important role in the control of avian colibacillosis, which is 90 
caused by avian pathogenic E. coli (APEC) strains (Guabiraba and Schouler, 2015; Mellata et 91 
al., 2003). Colibacillosis is the most relevant opportunistic bacterial infection of poultry. Its 92 
severity is frequently correlated to a primary viral infection, notably in regard to its 93 
pulmonary manifestation (Ariaans et al., 2008; Matthijs et al., 2009; Mosleh et al., 2017; 94 
Nakamura et al., 1994; Nolan et al., 2008; Umar et al., 2018; Umar et al., 2017).  95 
 96 
In the present study, we provided first insights on how chicken macrophages respond to type I 97 
IFNs. In addition, we have set up an in vitro model based on IFNα priming of chicken 98 
macrophages followed by stimulation with E. coli lipopolysaccharide (LPS) or infection with 99 
avian pathogenic E. coli (APEC) to assess the impact of type I IFNs on the macrophage 100 
response to bacterial challenge. Our data provide new information on the cellular and 101 
molecular determinants of chicken macrophage functions in an inflammatory milieu likely to 102 
be encountered during viral/bacterial co-infection in poultry. 103 
 104 
2. Materials and methods 105 
2.1. Reagents 106 
Lipopolysaccharide (LPS, from E. coli O55:B5) was purchased from Sigma-Aldrich, UK. 107 
Chicken IFNα and IFNβ were produced in E. coli and purified as previously described 108 
(Schultz et al., 1995a; Schultz et al., 1995b). Purified rabbit anti-chicken IFNβ antiserum was 109 
obtained as previously described (Schwarz et al., 2004). Recombinant chicken type I IFNs 110 
and IFNβ antiserum were tested negative for endotoxin contamination using HEK-Blue™ 111 
TLR4 cells designed for studying the stimulation of TLR4 by monitoring the activation of 112 
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NF-κB and AP-1 (InvivoGen, USA). SB-203580 (p38 MAP Kinase inhibitor) and 113 
Wortmannin (PI3-kinase/Akt inhibitor) were purchased from Tocris Bioscience, UK. BAY11-114 
7082 (IκB-α inhibitor) and BX795 (TBK1/IKKε inhibitor) were purchased from InvivoGen, 115 
USA. During the experiments, LPS, IFNα, IFNβ and IFNβ-antiserum were diluted in RPMI 116 
1640 medium (Gibco, UK). Inhibitors were diluted in dimethyl sulfoxide (DMSO, Sigma-117 
Aldrich, UK) and RPMI 1640 medium. Final concentration of DMSO in cell culture wells 118 
never exceeded 0.1%. 119 
2.2. Cell culture 120 
HD11, an avian myelocytomatosis virus (MC29)-transformed chicken macrophage-like cell 121 
line (Beug et al., 1979), was cultured in RPMI 1640 medium (Gibco, UK), supplemented with 122 
10% heat-inactivated fetal calf serum (FCS, Gibco, UK), 25 mM HEPES, 2 mM L-glutamine, 123 
100 U/ml penicillin and 100 µg/ml streptomycin (GE Healthcare, USA). HD11 cells were 124 
routinely grown in 75-cm2 flasks (Corning, USA) at 41°C and 5% CO2. 125 
An HD11-NFκB luciferase reporter cell line was constructed by infection of cells with 126 
replication-incompetent, lentivirus-based pseudoviral particles harboring a vector containing a 127 
basal promoter element (TATA box) and tandem repeats of an NFκB consensus sequence 128 
fused to a luciferase reporter gene (Cignal Lenti Reporters, SABiosciences, Frederick, 129 
Maryland, USA). Cell lines expressing the reporter fusion were selected under puromycin 130 
selection according to the manufacturer´s instructions, and individual clones purified by 131 
limited dilution. Clones were subsequently screened for NFκB activation in response to LPS 132 
and those showing high induction ratios with a low signal/noise ratio were retained. Cells 133 
were routinely cultured in DMEM F-12 (1:1) medium (Gibco, UK), supplemented with 10% 134 
heat-inactivated FCS, 15 mM HEPES, 2 mM L-glutamine, 100 U/ml penicillin, 100 µg/ml 135 
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streptomycin and 5 µg/ml puromycin (Sigma-Aldrich, UK), and incubated as described 136 
above. 137 
The CEC32-Mx-Luc and the CEC32-NFκB-Luc reporter cell lines are quail fibroblast cell 138 
lines carrying the luciferase gene under the control of chicken Mx promoter (Schwarz et al., 139 
2004) or carrying an NFκB-regulated luciferase reporter gene (Gyorfy et al., 2003), 140 
respectively. CEC32-Mx-Luc and the CEC32-NFκB-Luc were kindly provided by Prof. Peter 141 
Stäheli (University of Freiburg, Germany). CEC32 luciferase reporter cells were cultivated in 142 
DMEM GlutaMAX™-I supplemented with 8% heat-inactivated FCS, 2% heat-inactivated 143 
chicken serum (Gibco, UK), 4.5 g/l D-glucose, 100 U/ml penicillin, 100 µg/ml streptomycin 144 
and 50 µg/ml geneticin (G418) (Gibco, UK) and grown in 25-cm2 flasks (Corning, USA) at 145 
41°C and 5% CO2. 146 
Chicken bone marrow derived macrophages (chBMDM) were generated from bone marrow 147 
cells using recombinant chicken colony-stimulating factor 1 (CSF-1) (Garceau et al., 2010) 148 
produced in COS-7 cells (fibroblast-like cell line derived from monkey kidney tissue, ATCC, 149 
USA) transfected with a pTArget vector (Promega, UK) expressing chicken CSF-1 (kindly 150 
provided by Prof. Pete Kaiser, The Roslin Institute, UK). Briefly, femurs and tibias of 4 151 
week-old White Leghorn B13/B13 histocompatible chickens were removed, both ends of the 152 
bones were cut and the bone marrow was flushed with RPMI 1640 supplemented with 100 153 
U/ml penicillin and 100 µg/ml streptomycin. Cells were washed and re-suspended in RPMI 154 
1640 medium then loaded onto an equal volume of Histopaque-1077 (Sigma-Aldrich, UK) 155 
and centrifuged at 400 g for 20 min. Cells at the interface were collected and washed twice in 156 
RPMI 1640 medium. Purified cells were seeded at 1x106 cells/ml in sterile 60 mm 157 
bacteriological petri dishes in RPMI 1640 medium supplemented with 10% heat-inactivated  158 
FCS, 25 mM HEPES, 2 mM L-glutamine, 100 U/ml penicillin, 100 µg/ml streptomycin and 159 
COS-7 supernatant containing chicken CSF-1 at 41°C and 5% CO2. Half of the medium was 160 
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replaced with fresh medium containing chicken CSF-1 at day 3. At day 6 adherent cells were 161 
harvested and washed in phosphate buffered saline (PBS, Gibco, UK) supplemented with 2 162 
mM Ethylenediaminetetraacetic acid (EDTA, Sigma-Aldrich, UK) and re-suspended in RPMI 163 
1640 supplemented with 10% heat-inactivated FCS, 25 mM HEPES, 2 mM L-glutamine, 100 164 
U/ml penicillin and 100 µg/ml streptomycin. 165 
Chicken lung macrophages were obtained from transgenic birds expressing the fluorescent 166 
mApple reporter under control of promoter and enhancer elements of the chicken CSF1R 167 
locus (Balic et al., 2014) as described previously (Jansen et al. 2010). Briefly, lungs from 4 168 
week-old MacRed chickens were removed, cut into pieces, and incubated with a DNAse 169 
I/collagenase A mix (1 mg/ml and 3 mg/ml, respectively; Sigma-Aldrich, UK) diluted in 170 
supplement free RPMI 1640 medium for 30 min at 41°C and 5% CO2. The digested tissue 171 
suspension was filtered through a 70 µm strainer, washed with PBS, and leukocytes were 172 
purified using a density gradient as described above. Cells at the interface were collected and 173 
washed twice in PBS. Cells were cultured at 1.5x106 cells/ml in 6-well plates in a final 174 
volume of 5 ml with RPMI 1640 medium supplemented with 10% heat-inactivated FCS, 2 175 
mM L-glutamine, 100 U/ml penicillin, 100 µg/ml streptomycin and 200 ng/ml of CSF-1 at 176 
41°C and 5% CO2 for 24h. The next day, culture medium containing non-adhered cells was 177 
removed and replaced with fresh complete RPMI 1640 medium without CSF-1 for the 178 
experimental treatment. The number of adherent macrophages was evaluated in parallel by 179 
flow cytometry and was approximately 5x105 cells per well. 180 
2.3. In vitro stimulation protocol 181 
HD11 and chBMDM cells were seeded in 12-well plates at 5x105 cells/well and 7.5x105 182 
cells/well, respectively, and incubated at 41°C and 5% CO2 overnight prior to stimulation. 183 
Chicken lung macrophages at 5x105 cells/well were obtained as described above and not re-184 
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seeded. Next, the cells were pretreated for 16h with chicken recombinant IFNα (50 ng/ml) 185 
unless otherwise indicated. Cells were gently washed with PBS prior to stimulation with IFNα 186 
(50 ng/ml), LPS (10 ng/ml), purified IFNβ-antiserum (17.5 µg/ml) or IFNβ (50 ng/ml) at 187 
different treatment combinations and at different time-points. In all experiments, mock 188 
controls were treated with medium or medium with 0.1% DMSO (when pharmacological 189 
inhibitors were used). Supernatants were harvested and stored at -20°C after stimulation for 190 
further analysis. HD11 cells and chBMDM were washed in PBS and lysed with RNA lysis 191 
buffer (Macherey-Nagel, Germany) containing 2-mercaptoethanol (Merck Millipore, 192 
Germany), snap frozen in liquid nitrogen and stocked at -80°C until RNA extraction. Chicken 193 
lung macrophages were washed in PBS and lysed with RNA lysis buffer (Qiagen, Germany) 194 
containing 2-mercaptoethanol. For protein dosage and western blot analysis, cells were 195 
washed in PBS followed by cell lysis using Laemmli Sample Buffer (BioRad, USA) 196 
containing a proteases inhibitors cocktail (Santa Cruz Biotechnology, USA) and 2.5% 2-197 
mercaptoethanol, and stocked at -20°C. 198 
2.4. Experimental design for in vitro infection 199 
HD11 were seeded in 12-well plates at 5x105 cells/well and chicken lung macrophages were 200 
used at a final number of 5x105 cells/well in 6-well plates (in which they were obtained) in 201 
complete RPMI 1640 medium, and incubated at 41°C under 5% CO2 overnight. The APEC 202 
strains used for infections were BEN2908 (O2:K1:H5), a nalidixic acid-resistant derivative of 203 
strain MT78 which was isolated from the trachea of a chicken with respiratory infection (Dho 204 
and Lafont, 1982) or BEN2908 harboring pFPV25.1 (a plasmid expressing GFP) (Valdivia 205 
and Falkow, 1996). Bacteria were diluted at the appropriate concentration in supplement-free 206 
RPMI 1640 medium, and cells were infected at a multiplicity of infection (MOI) of 10 207 
followed by incubation at 41°C under 5% CO2. The mock control group received supplement-208 
free RPMI 1640 medium without bacteria. After 1h (adhesion period), one group of APEC-209 
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infected HD11 cells were washed with PBS then lysed with PBS containing 0.1% Triton X-210 
100 (Sigma-Aldrich, UK). Bacteria in the cell lysates were plated onto LB agar plates to 211 
evaluate the number of adherent bacteria (colony-forming units). For the other groups, HD11 212 
or chicken lung macrophages were gently washed with PBS and remaining extracellular 213 
bacteria were killed by incubating cells with FCS-free medium containing gentamicin (100 214 
µg/ml) for 1h 30 min. Cells were then lysed with 1X PBS containing 0.1% Triton X-100 or 215 
harvested in FACS buffer (PBS supplemented with 2% heat-inactivated FCS and 2 mM 216 
EDTA) for further flow cytometry analysis. Remaining intracellular viable bacteria were 217 
plated onto LB agar to determine the number of intracellular bacteria. For gene expression 218 
analysis, an additional group of HD11 cells were infected as described above, and incubated 219 
with medium containing gentamicin (10 µg/ml) for 6h. Cells were washed with PBS then 220 
lysed with RNA lysis buffer (Macherey-Nagel, Germany). 221 
2.5. Flow cytometry analysis 222 
Cell viability following different stimuli was assessed using the chicken Annexin V 223 
Fluorescein kit (Kingfisher Biotech, USA) and the fluorescent DNA intercalator 7-224 
aminoactinomycin D (7-AAD, BD Biosciences, USA) as markers of apoptosis and necrosis, 225 
respectively. HD11 cells were seeded at 2x105 cells/well in 24-well plates and pretreated with 226 
IFNα (50 ng/ml) (unless otherwise indicated). Following stimulation with IFNα (50 ng/ml) or 227 
LPS (10 ng/ml) for 6h, supernatants were discarded and the cells were harvested and washed 228 
in PBS. Cells were stained according to the manufacturer’s protocol and the viability was 229 
analyzed by flow cytometry (BD FACS Calibur). Data were expressed as the percentage of 230 
cells undergoing late apoptosis/necrosis (Annexin V+ 7-AAD+) over total acquired events 231 
(50,000 cells). 232 
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Expression of co-stimulation markers on the chicken macrophage HD11 cell line was also 233 
assessed. HD11 cells were treated as described above and harvested in FACS buffer (PBS 234 
supplemented with 2% heat-inactivated FCS and 2 mM EDTA). Cells were washed and 235 
incubated for 45 min at 4°C with a mouse anti-chicken CD40 antibody (BioRad, USA) at a 236 
1:200 dilution or with the respective isotype control (BioRad) at a 1:200 dilution. Cells were 237 
again washed and incubated for 45 min with a rat anti-mouse IgG-specific secondary antibody 238 
coupled to fluorescein isothiocyanate (FITC, Thermo Fisher Scientific, USA). In a separate 239 
staining protocol, cells were also stained with a mouse anti-chicken MHC class II FITC 240 
(BioRad) or with the respective isotype control (BioRad) at a 1:200 dilution for 45 min. HD11 241 
cells were washed and re-suspended in FACS buffer prior to analysis. Data were expressed as 242 
Mean Fluorescence Intensity (MFI) from FITC+ cell populations over total acquired events 243 
(50,000 cells). 244 
Bacterial fluorescence was assessed by flow cytometry. Briefly, chicken lung macrophages 245 
(5x105 cells/well in 6-well plates) were pretreated with the different stimuli and infected as 246 
described above. Lung macrophages were detached from the plate using TrypLE Express 247 
(Invitrogen, USA) for 15 min, washed, and harvested in FACS buffer prior to analysis (BD 248 
LSRFortessa™). SYTOX Blue Dead Cell Stain (Invitrogen, USA) was added to discriminate 249 
live and dead cells. Data were expressed as Mean Fluorescence Intensity (MFI) from GFP+ 250 
cell populations over total acquired events (50,000 live cells). 251 
2.6. Gene expression analysis 252 
Total RNA from HD11 cells and chBMDM was extracted from frozen cell lysates using the 253 
NucleoSpin® RNA kit (Macherey-Nagel, Germany) according to the manufacturer's 254 
instructions, while total RNA from lung macrophages was extracted using the RNeasy® Mini-255 
Kit (Qiagen, Germany). Both protocols contained a DNAse treatment step. RNA quality and 256 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
concentration were determined by NanoDrop spectrophotometric measurement (Thermo 257 
Scientific, USA). Total RNA (up to 1 µg per reaction) was reverse transcribed using iScript 258 
Reverse Transcription Supermix for RT-qPCR (Bio-Rad, USA). Quantitative Real-time PCR 259 
(qRT-PCR) was performed on a CFX96 machine (Bio-Rad, USA). The reaction mixture was 260 
composed of cDNA, iQ SYBR Green Supermix (Bio-Rad, USA), primer pairs (Eurogentec, 261 
Belgium) and nuclease-free water (Sigma-Aldrich, UK) in a total volume of 10 µl. qRT-PCR 262 
data were analyzed using the CFX Manager software 3.1 (Bio-Rad, USA). Gene expression 263 
for each target gene was normalized to gene expression levels of chicken hypoxanthine-264 
guanine phosphoribosyltransferase (HPRT), β-2-microglobulin (β2M) and/or glyceraldehyde-265 
3-phosphate dehydrogenase (GAPDH). A list of primer pairs utilized in the present study is 266 
given in Table 1. Relative normalized expression was calculated using the 2−∆∆Ct method 267 
and data are represented as fold increase as compared to control (or mock) groups. Baseline 268 
cycle threshold (Ct) values for the target genes in HD11 cells, chBMDM and lung 269 
macrophages are shown in Supplementary Table 1. 270 
2.7. NO and ROS production 271 
Nitrite (NaNO2) concentration, as an index of nitric oxide (NO) production, was determined 272 
by spectrophotometry in cell culture supernatants using a standard Griess assay according to 273 
the manufacturer’s instructions (Promega, UK). The absorbance was read at 550 nm in a 274 
Multiskan Ascent plate reader (Thermo Fisher Scientific, USA). The nitrite concentration was 275 
calculated using a sodium nitrite standard curve.  276 
ROS (Reactive Oxygen Species) production was evaluated by flow cytometry using the 277 
CellROX® Green Reagent kit (Invitrogen, USA) according to the manufacturer’s instructions. 278 
Briefly, HD11 cells were seeded at 2x105 cells/well in 24-well plates and pretreated with 279 
IFNα (50 ng/ml) for 16h (unless otherwise indicated). Next, cells were gently washed with 280 
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PBS then incubated with fresh medium containing LPS (10 ng/ml) or IFNα (50 ng/ml) for 6h 281 
before the addition of CellROX® Green Reagent for 30 min. Cells were washed, harvested in 282 
FACS buffer and ROS production was determined by flow cytometry analysis (BD FACS 283 
Calibur). Data were expressed as Mean Fluorescence Intensity (MFI) from green fluorescent+ 284 
cell population over total acquired events (50,000 cells). 285 
2.8. Western blot 286 
Total protein was quantified using a Quick Start™ Bradford Protein Assay (Bio-Rad, USA). 287 
15 µL of protein-containing lysates were separated on a 12% polyacrylamide gel in Tris-288 
Glycin-SDS buffer (25 mM, 200 mM and 0.5% respectively) and transferred to Porablot® 289 
nitrocellulose membranes (0.45 µm) (Macherey-Nagel, Germany) using a Mini Trans-Blot® 290 
cell (Bio-Rad) in 1X CAPS (3-(cyclohexylamino)-1-propanesulfonic acid) buffer. Following 291 
overnight immersion at 4°C in a blocking solution (3% non-fat milk powder in buffer 292 
containing 10 mM Tris, 150 mM NaCl and 0.1% Tween 20), the membranes were washed 293 
and incubated for 1h at RT with a mouse anti-GAPDH antibody (MAB374, Millipore, USA) 294 
at a 1:500 dilution (3% milk powder in Tris-NaCl-Tween buffer), a rabbit anti-p38 antibody 295 
(#9212, Cell Signaling, USA) at a 1:1000 dilution, a rabbit anti-phospho-p38 antibody 296 
(#9211, Cell Signaling) at a 1:1000 dilution, a mouse anti-STAT1 antibody (1/Stat1, BD 297 
Bioscience, USA) at a 1:1000 dilution, a rabbit anti-phospho-STAT1 antibody (15H13L67, 298 
Life Technologies, USA) at a 1:1000 dilution, a rabbit anti-Akt (pan) antibody (#4691, Cell 299 
Signaling) at a 1:1000 dilution, a rabbit anti-phospho-Akt1/2/3 antibody (sc-7985-R, Santa 300 
Cruz Biotechnology) at a 1:1000 dilution, a mouse anti-phospho-IκBα (Ser32/36) antibody 301 
(#9246, Cell Signaling) at a 1:1000 dilution, a rabbit anti-p44/42 MAPK (Erk1/2) antibody 302 
(#4695, Cell Signaling) at a 1:1000 dilution or a rabbit anti-phospho-p44/42 MAPK (Erk1/2) 303 
antibody (#4377, Cell Signaling) at a 1:1000 dilution. Membranes were washed three times 304 
and incubated for 1h at RT with a mouse or rabbit IgG-specific secondary antibody coupled to 305 
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horseradish peroxidase (HRP, Sigma) at a dilution of 1:10000 (3% milk powder in Tris-NaCl-306 
Tween buffer). After washing, the membranes were overlaid with the WesternBright® ECL 307 
peroxidase substrate (Advansta) and chemiluminescence was visualized using a Fusion-FX 308 
imaging platform (Vilber Lourmat, France).  309 
2.9. Luciferase reporter assays 310 
Type I IFN and IL1β production in supernatants of stimulated chicken HD11 cells or 311 
chBMDM was measured using luciferase-based Mx- or NFκB-reporter bioassays, 312 
respectively (Gyorfy et al., 2003; Schwarz et al., 2004). Briefly, CEC32-Mx or CEC32-NFκB 313 
cells were seeded at 2.5x105 cells/well in 24-well plates and incubated at 41°C under 5% CO2 314 
overnight. The next day, cells were incubated for 6h with the diluted supernatants (1/10 of 315 
total volume) from stimulated HD11 or chBMDM cell cultures. Medium was removed and 316 
cells were washed twice with PBS. Cells were lysed using the Cell Culture Lysis Reagent 317 
(Promega, USA), according to the manufacturer’s instructions, and luciferase activity was 318 
measured using the Luciferase assay reagent (Promega, USA) and a GloMax-Multi Detection 319 
System (Promega, USA). Data were expressed as IFNβ or IL1β activity (fold increase as 320 
compared to control group). 321 
For NFκB activity measurement in HD11 cells, HD11-NFκB reporter cells were seeded at 322 
2.5x105 cells/well in 24-well dishes and incubated at 41°C under 5% CO2 overnight. The next 323 
day, HD11-NFκB cells were incubated for 6h with the indicated stimuli and inhibitors at the 324 
appropriate concentration. Next, medium was removed and cells were treated as described for 325 
CEC32-Mx or CEC32-NFκB cells. Data are expressed as NFκB activity (fold increase 326 
relative to the control or mock group). 327 
2.10. Phagocytosis and endocytosis assay 328 
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Phagocytosis or endocytosis (fluid-phase pinocytosis and receptor-mediated endocytosis) 329 
capacity of HD11 cells were evaluated by flow cytometry using pHrodo™ Green E. coli 330 
BioParticles® Conjugate or pHrodo™ Green Dextran (Invitrogen, USA), respectively. 331 
Briefly, HD11 cells were seeded in 48-well plates at 2x105 cells/well and incubated at 41°C 332 
under 5% CO2 overnight. Then, cells were pretreated with IFNα (50 ng/ml) for 16h (unless 333 
otherwise indicated). The next day, cells were gently washed with PBS then incubated with 334 
fresh incomplete RPMI 1640 containing pHrodo™ Green Dextran at 50 µg/ml or with 335 
incomplete RPMI 1640 containing unopsonized pHrodo™ Green E. coli BioParticles® 336 
Conjugate at 333 µg/ml for 30 min and 1h, respectively. Cells were washed then harvested 337 
with pre-warmed FACS buffer and subsequently analyzed by flow cytometry (BD FACS 338 
Calibur). Data were expressed as the percentage of pHrodo green+ cell populations over total 339 
acquired events (50,000 cells). 340 
2.11. Statistical analysis 341 
Comparisons between two groups were performed using a two-tailed unpaired Student’s t test. 342 
Multiple groups were compared using a one-way ANOVA analysis followed by a Tukey 343 
multiple comparison post-hoc test. Values for all measurements are expressed as mean ± 344 
SEM. P<0.05 was considered statistically significant. Data are representative of at least two 345 
independent experiments unless otherwise indicated. Statistical analysis was performed using 346 
the GraphPad Prism 6.0 software (GraphPad Software, USA). 347 
 348 
3. Results 349 
3.1. IFNα and IFNβ elicit different intracellular responses in chicken 350 
primary macrophages 351 
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To gain first insights into the functional roles played by type I IFNs in chicken primary 352 
macrophages, we compared the expression profiles of various ISGs, IFN-regulatory 353 
transcription factors and the pro-inflammatory responses elicited by IFNα and IFNβ. At 2h 354 
(data not shown) and 6h following type I IFNs stimulation, chBMDM showed increased 355 
expression of the ISGs 2’-5’ oligoadenylate synthetase (OAS1), myxovirus resistance protein 356 
(MX1), double-stranded RNA-activated protein kinase (EIF2AK2) and signal transducer and 357 
activator of transcription 1 (STAT1) as compared to the mock control group (Figure 1A). 358 
Among the ISGs and associated transcription factors, only the expression of interferon 359 
regulatory factor 7 (IRF7) proved to be more elevated after IFNβ stimulation at the tested 360 
time-points, while all other ISGs were more efficiently induced by IFNα. Yet, pro-361 
inflammatory genes such as IL1B, IFNB, IL6 and IL8L2 were markedly up-regulated upon 362 
IFNβ treatment as compared to cells treated with IFNα (Figure 1B). Our data therefore 363 
demonstrated that, at least at early time-points, both type I IFNs play a role in triggering ISGs 364 
expression, but IFNβ has a more pronounced effect on pro-inflammatory cytokine gene 365 
expression in chBMDM. 366 
In mammals, STAT1, mitogen-activated protein kinases (MAPKs) p38 and p44/42 (Erk1/2), 367 
PI3K/Akt, and NFκB pathways have been shown to be involved in type I IFN signalling 368 
(Hervas-Stubbs et al., 2011). We therefore performed western blot analyses to investigate 369 
whether some of these signalling pathways were triggered by type I IFNs in chBMDM. 370 
STAT1 expression was strongly induced from 6h to 24h upon exposure to IFNα as compared 371 
to the mock control group (Figure 2A). These results confirmed that the upregulation of 372 
STAT1 protein is correlated to the gene expression data (Figure 1A). Furthermore, IFNα 373 
stimulation markedly induced early phosphorylation and activation of STAT1 (pSTAT1), 374 
which lasted for up to 24h, as compared to the mock control group. In contrast to the situation 375 
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in cells stimulated with IFNα, STAT1 and pSTAT1 were only slightly induced by IFNβ, both 376 
displaying a modest, yet sustained induction at 24h post-stimulation (Figure 2A). 377 
We also found that p38 MAPK, p44/42 MAPK and Akt were constitutively expressed in 378 
chBMDM (Figure 2A). The p38 MAPK phosphorylated form (pp38) was expressed from 30 379 
min to 6h following stimulation with IFNα or IFNβ. Only low levels of pp38 were detected 380 
24h after stimulation with both type I IFNs, suggesting that the p38 MAPK pathway is 381 
activated only at early time-points following stimulation. In contrast to the rapid and clear 382 
expression pattern observed for pp38, pp44/42 expression was weakly induced from 2h to 24h 383 
following stimulation with IFNα or IFNβ. This might suggest a minor (or indirect) role of 384 
these cytokines in the activation of this pathway in chBMDM. In regard to the PI3K/Akt 385 
pathway, pAkt expression was weakly induced by IFNα. However, stimulation with IFNβ 386 
markedly upregulated pAkt expression as early as 1h, with a quick decrease to mock control 387 
group levels after 2h. Therefore, the PI3K/Akt pathway is likely to be better activated by 388 
IFNβ as compared to IFNα in chBMDM. Finally, we investigated the role of type I IFNs in 389 
the expression of proteins involved in the activation of NFκB. Activation occurs via 390 
phosphorylation of IκBα at Ser32 and Ser36 followed by proteasome-mediated degradation 391 
that results in the release and nuclear translocation of active NFκB (Hayden and Ghosh, 392 
2008). Although we could not detect the expression of IkBα in chBMDM using the present 393 
western blot protocol and commercially available antibodies (data not shown), we 394 
demonstrated that IFNβ, but not IFNα, induced a marked expression of pIκBα (Ser32/36) at 395 
6h post-stimulation (Figure 2A). 396 
To better characterize the potential activation NFκB by type I IFNs, we used an HD11-NFκB 397 
luciferase reporter cell line. Cells were stimulated for 6h with IFNα or IFNβ, and LPS 398 
treatment was included as a positive control. As expected, and consistent with its incapacity to 399 
directly induce a pro-inflammatory profile, the NFκB pathway was not triggered by IFNα. In 400 
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contrast, it was strongly activated by IFNβ as compared to the mock control group (Figure 401 
2B), which is in line with its ability to induce phosphorylation of IkBα at 6h (Figure 2A). In 402 
addition, we observed that pharmacological inhibition of the intracellular signalling pathways 403 
p38 MAPK, PI3K/Akt and TBK1/IKKε partially reduced the activation of NFκB induced by 404 
IFNβ (Figure 2B). The 7-AAD staining protocol revealed that none of the inhibitors were 405 
found to be cytotoxic (necrotic cell death) at the concentrations used (data not shown). These 406 
data suggest that the signalling pathways studied are likely to be involved in the activation of 407 
NFκB following stimulation with IFNβ. 408 
Taken together, our results revealed that IFNα and IFNβ play different roles in the induction 409 
of chicken macrophage intracellular signalling pathways upstream of the transcriptional 410 
regulation of ISGs or pro-inflammatory genes. 411 
 412 
3.2. IFNα elicits similar response patterns in a chicken macrophage cell line 413 
and in lung macrophages 414 
IFNα is the best studied type I IFN in birds (Giotis et al., 2016; Goossens et al., 2013; Roll et 415 
al., 2017; Santhakumar et al., 2017). We therefore complemented our findings by assessing 416 
the impact of IFNα in the well-established chicken macrophage cell line HD11 (Beug et al., 417 
1979). Incubation of HD11 cells with IFNα for 6h led to a marked increase in the expression 418 
of the ISGs OAS1, MX1 and EIF2AK2 as compared to the mock control group (Figure 3A). 419 
The interferon-regulated transcription factors IRF7 and STAT1 likewise showed a significant 420 
increase in their transcriptional expression (3 and 7 fold, respectively) (Figure 3A). IFNα 421 
stimulation did not alter IL1B, NOS2, IFNA and IFNB gene expression and nitric oxide (NO) 422 
production in HD11 supernatants (Figure 3B). Furthermore, we confirmed by flow cytometry 423 
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analysis using Annexin V and 7-AAD staining that IFNα was not cytotoxic (late 424 
apoptosis/necrosis) to HD11 cells after 6h or 16h of stimulation (Figure 3C).  425 
To better improve our knowledge on the responses elicited by IFNα in chicken macrophages, 426 
gene expression data for HD11 cells were compared to those obtained from chicken lung 427 
macrophages at a matching time-point (6h). Except for OAS1, ISGs expression in lung 428 
macrophages was significantly higher (307%, 154%, 300% and 100% for EIF2AK2, MX1, 429 
IRF7 and STAT1, respectively) than those found in HD11 cells (Figure 3D). Interestingly, the 430 
baseline Ct values for the aforementioned ISGs (except for OAS1) are very similar between 431 
HD11 cells and lung macrophages (Supplementary Table 1). Similarly to HD11 cells, no 432 
increase in pro-inflammatory gene expression was observed (data not shown).  433 
Consequently, the HD11 cell line was used in most experiments of the present study, because 434 
of its easy accessibility, handling, and maintenance. Nevertheless, the most relevant findings 435 
were further confirmed using chicken primary macrophages. 436 
 437 
3.3. IFNα priming potentiates the pro-inflammatory response to E. coli LPS 438 
in chicken macrophages 439 
As demonstrated in chicken lung macrophages and in a cell line, IFNα strongly induced ISGs 440 
but a negligible pro-inflammatory gene expression profile. Indeed, IFNα has been used in 441 
priming strategies to assess the impact of type I IFNs in cellular responses to cytokines, 442 
pathogen-associated molecular patterns (PAMPs) or pathogens in chickens and mammalian 443 
species (Doughty et al., 2001; Jiang et al., 2011; Pei et al., 2001; Sharif et al., 2004). We 444 
therefore asked whether a type I IFN enriched environment, likely to be encountered during 445 
viral infections, could modulate the chicken macrophage inflammatory response to E. coli 446 
LPS. We stimulated HD11 cells by incubating them with IFNα for 16h (priming time). 447 
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Shorter and longer exposition times were tested and showed to be less effective in inducing a 448 
non-cytotoxic priming activity in this macrophage cell line (data not shown). HD11 cells were 449 
subsequently stimulated for 6h with E. coli LPS (Figure 4A), a time point where gene 450 
expression or NO production were peaking or produced consistently reproducible data.  451 
We observed that IFNα priming followed by LPS stimulation (IFNα prm + LPS) markedly 452 
upregulated IL1B, NOS2 and IFNB gene expression, concomitant with NO and ROS 453 
production, as compared to the group treated with LPS alone (Figure 4B and 4C). The same 454 
stimulating effect was observed for the expression of the genes of interest at 2h (data not 455 
shown). As expected, IFNα priming (IFNα prm) alone and IFNα stimulation (6h) had no 456 
effect on pro-inflammatory gene expression and were ineffective in promoting ROS or NO 457 
production (Figure 4B and 4C). We next used a bioassay to verify whether the IFNB 458 
upregulation was associated to IFNβ production by chicken macrophages. Under all treatment 459 
conditions tested, IFNA gene expression was assed using different primer pairs (data not 460 
shown) and was found to be never induced in HD11 cells, suggesting that the type I IFN 461 
bioactivity determined in the bioassay would largely rest on IFNβ production. Corroborating 462 
the gene expression data, we observed that more IFNβ was produced following LPS 463 
stimulation when HD11 cells were previously primed with IFNα (Figure 5A). Although IFNα 464 
priming potentiated the pro-inflammatory response to LPS, no additional cytotoxic effect was 465 
observed when both molecules were added to the cells as compared to the group receiving 466 
LPS alone (Figure 5B).   467 
In addition, we evaluated the impact of IFNα and/or LPS on the expression of co-stimulation 468 
markers by HD11 cells. Only LPS was able to upregulate CD40 expression, whereas IFNα 469 
priming had no potentiating effect (Figure 5C). However, MHC II expression was increased 470 
by IFNα priming (16h), but not by IFNα stimulation (6h). The addition of LPS did not 471 
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increase MHC II expression in priming or mock conditions at the same time-points (Figure 472 
5C). 473 
We confirmed these results by using chBMDM and applying the same experimental approach. 474 
IL1B, NOS2, IFNB expression, and NO, IFNβ and IL-1β production (as assessed using the 475 
CEC32-NFκB reporter cell line), were all upregulated when chBMDM were primed with 476 
IFNα for 16h and then challenged with LPS for 2h (data not shown) or 6h (Supplementary 477 
Figure 1A and 1B). Interestingly, we observed that IFNα stimulation induced IL1B and 478 
NOS2 expression concomitant with NO production, which rapidly decreased to control group 479 
levels. Notably, neither gene expression nor NO production was observed in the IFNα primed 480 
group (16h), therefore excluding any potential cumulative effects on the priming approach. 481 
Strikingly, the bioassay revealed that IFNβ was also produced in the IFNα primed group. 482 
However, HD11 cells were washed with PBS after the priming to avoid any contamination of 483 
IFNα in the culture supernatant, therefore suggesting a sustained secretion of IFNβ by these 484 
cells (Supplementary Figure 1B).  485 
In conclusion, IFNα priming favours the development of an increased pro-inflammatory 486 
response to E. coli LPS in chicken macrophages without entailing cytotoxic effects. 487 
Moreover, IFNα increases MHC II expression on the HD11 cell line, suggesting an increased 488 
antigen presentation potential. 489 
 490 
3.4. IFNβ mediates the increased pro-inflammatory response to E. coli LPS 491 
in chicken macrophages following IFNα priming 492 
We observed that IFNβ production induced by LPS was strongly enhanced by IFNα priming 493 
in chicken macrophages. Previous studies have demonstrated that IFNβ is involved in 494 
different pro-inflammatory processes in mammals and chickens (de Weerd and Nguyen, 495 
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2012; Hervas-Stubbs et al., 2011; Santhakumar et al., 2017). We therefore speculated that 496 
IFNβ could be involved in the onset of a pro-inflammatory state induced by IFNα priming. To 497 
test this, HD11 cells were treated as described earlier and a rabbit anti-chicken IFNβ-498 
antiserum was added along with LPS in order to neutralize IFNβ released into the medium. As 499 
shown in Figure 6A, in the group primed with IFNα and subsequently challenged with LPS 500 
for 2h (data not shown) and 6h, the addition of IFNβ-antiserum (right bars) virtually 501 
abrogated the potentiation effects of the priming protocol on IL1B, NOS2 and IFNB 502 
expression, and on NO and IFNβ production. Importantly, IFNβ-antiserum did not affect the 503 
pro-inflammatory response induced by LPS alone (Figure 6A), and IFNβ-antiserum was not 504 
cytotoxic for chicken macrophages (Figure 6B). 505 
The same experiments were also performed using chBMDM, in which IFNβ-antiserum 506 
addition similarly abrogated the potentiating effect of IFNα priming on the LPS-induced pro-507 
inflammatory response (Supplementary Figure 2). To corroborate our findings, we also 508 
incubated chBMDM with LPS and IFNβ. We observed that, when added together, LPS and 509 
IFNβ mimicked the potentiating pro-inflammatory effect induced by IFNα priming (Figure 510 
6C). 511 
Our data thus suggest that IFNβ is a key mediator of the increased pro-inflammatory response 512 
to LPS observed in chicken macrophages previously primed with IFNα.   513 
 514 
3.5. IFNα priming potentiates chicken macrophage pro-inflammatory 515 
responses to APEC infection paralleled by an increased phagocytosis 516 
capacity 517 
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Since IFNα priming potentiates the chicken macrophage pro-inflammatory response to E. coli 518 
LPS, we next explored whether IFNα priming modulates the macrophage response to avian 519 
pathogenic E. coli (APEC) infection. HD11 cells were primed with IFNα for 16h then 520 
infected with the highly adhesive/invasive APEC strain BEN2908 at an MOI of 10 for 6h. 521 
Cells primed with IFNα and infected with the APEC strain (IFNα prm + APEC) showed an 522 
up-regulation of IFNB expression, concomitant with an increased NO and IFNβ production, 523 
when compared to the non-primed BEN2908-infected group (APEC) (Figure 7A). IL1B was 524 
also up-regulated in the primed group, but no statistical difference was seen compared to the 525 
non-primed APEC group (Figure 7A).  526 
In addition, we counted intracellular bacteria at 1h and 2h 30 min post infection in order to 527 
assess the number of adhered and intracellular bacteria, respectively. Bacterial adhesion was 528 
not affected by IFNα priming (Figure 7B) whereas the number of viable intracellular bacteria 529 
was significantly increased when macrophages were primed with IFNα (Figure 7C). 530 
We next asked whether the increased intracellular bacterial load could be mediated by an 531 
IFNα-dependent enhancement of the endocytic or phagocytic capacity of HD11 cells. 532 
Subsequent to several pilot experiments to identify the best time-points and reagents 533 
concentrations to be used in these experiments (data not shown), endocytosis (fluid-phase 534 
pinocytosis and receptor-mediated endocytosis) and phagocytosis were evaluated by flow 535 
cytometry using fluorescent particles. We found that IFNα priming did not impact 536 
endocytosis (Figure 7D) but it was able to significantly enhance the phagocytosis capacity of 537 
chicken macrophages (20% increase) (Figure 7E).  538 
The increase in intracellular bacterial uptake observed in HD11 cells following IFNα priming 539 
was confirmed in experiments with chicken lung macrophages using a BEN2908 strain 540 
expressing the GFP (Figure 7F). In addition, intracellular bacterial fluorescence was assessed 541 
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by flow cytometry and found to be higher in lung macrophages primed with IFNα (Figure 542 
7G).  543 
Altogether, these results evidenced that IFNα priming potentiates the pro-inflammatory 544 
response to APEC infection in chicken macrophages paralleled by an increased phagocytic 545 
activity, without detectable bactericidal consequences.  546 
 547 
4. Discussion 548 
Macrophage functions such as pathogen recognition, phagocytosis and cytokine expression 549 
have been shown to be greatly impacted by type I IFNs in mammalian systems (Lee et al., 550 
2015; Nakamura et al., 2011; Shahangian et al., 2009; Shepardson et al., 2016). In chickens, 551 
although extensive work have been done to understand type I IFN biology and their inhibitory 552 
effects on virus replication (Giotis et al., 2016; Jiang et al., 2011; Mo et al., 2001; Pei et al., 553 
2001; Roll et al., 2017), many aspects of the type I IFN response remain unexplored, notably 554 
in regard to macrophages and their inflammatory response. Our data revealed that for chicken 555 
primary macrophages IFNα was a more potent inducer of ISGs expression (OAS, MX1, PKR 556 
and STAT1) when compared to IFNβ at 6h post stimulation. In contrast, at the same time point 557 
post stimulation, IFNβ proofed to be a better inducer of pro-inflammatory cytokine gene 558 
expression (IL1B, IFNB, IL6 and IL8L2). A previous study using the DF-1 chicken fibroblast 559 
cell line showed that IFNα stimulation entails a strong antiviral profile, mainly through a 560 
marked upregulation of ISGs associated to robust antiviral activity (Qu et al., 2013). In 561 
contrast, IFNβ appears to rather drive an immune modulatory response. Our data obtained 562 
with chicken macrophages are in good agreement with this observation. Several hypothesis 563 
have been made to explain these differential effects, including putative different affinities of 564 
type I IFNs to the subunits of their cognate receptor (IFNAR1 and IFNAR2) (Santhakumar et 565 
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al., 2017). However, type I IFN signalling and the resulting gene expression patterns are 566 
likely to be different between chicken macrophages and fibroblasts, due to the different 567 
biological functions of these cells. 568 
The distinct activity profiles observed for type I IFNs in the present study might be explained 569 
by differences in the activation of intracellular signalling pathways. In mammals, STAT1 is 570 
an important mediator of the JAK/STAT pathway in type I IFNs signalling, leading to the 571 
transcription of ISGs (Hervas-Stubbs et al., 2011). In chicken macrophages, STAT1 572 
phosphorylation was only weakly induced by IFNβ, but remained on a steady level 573 
throughout the stimulation period. In contrast, IFNα rapidly induced STAT1 phosphorylation. 574 
We speculate that the differences in ISGs expression induced by the two type I IFNs is 575 
directly linked to differential STAT1 pathway activation. Conversely, the p38 MAPK 576 
pathway exhibited the same activation kinetics in response to both IFNα and IFNβ. The role 577 
of this signalling pathway for the induction of ISGs and other genes downstream of the type I 578 
IFN receptor IFNAR has been demonstrated in mice (Li et al., 2004), but remains unclear in 579 
birds. 580 
Although 6h and 16h stimulation with IFNα alone was not found to strongly induce 581 
transcriptional expression of IL1B, NOS2, and IFNB in HD11 cells and primary macrophages, 582 
it potentiated the pro-inflammatory response to E. coli LPS, APEC LPS (data not shown) and 583 
APEC infection. We hypothesize that IFNα may prime or modify intracellular events in the 584 
macrophages, such as increasing the expression, production and/or activation of so far 585 
unrecognized transcription factors, thereby promoting the IFNβ over-production observed 586 
after challenge with bacterial molecular patterns. In mammals, type I IFNs act through 587 
JAK/STAT, CRB, PI3K/Akt, NFκB and MAPK signalling pathways (Hervas-Stubbs et al., 588 
2011), which are still largely unexplored in chickens due to the lack of species-specific 589 
pharmacological inhibitors and antibodies. One study has previously demonstrated that 590 
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chicken IFNα and IFNβ promoters share binding regions for transcription factors of the IRF 591 
family, and that the IFNβ promoter has an additional NFκB binding site (Sick et al., 1998). 592 
We demonstrated here that only IFNB gene expression was induced after bacterial challenge, 593 
in agreement with previously published data (Barjesteh et al., 2014). IFNβ is known to induce 594 
NFκB activation (Hervas-Stubbs et al., 2011). We therefore assume that the NFκB pathway 595 
may be involved in IFNβ production induced by LPS and in the inflammatory responses 596 
elicited by IFNβ. In fact, when we compared the effects of IFNα and IFNβ using the HD11-597 
NFκB reporter cell line and by assessing the phosphorylation of IkBα, we observed that IFNα 598 
did not activate this pathway, contrary to what was observed for IFNβ. On the other hand, in 599 
chicken primary macrophages, IFNα stimulation led to increased IL1B and NOS2 gene 600 
expression, all of which have been shown to be induced by the NFκB pathway upon LPS 601 
stimulation in mammals and chickens (Aktan, 2004; Contassot et al., 2012; He and Kogut, 602 
2003; Weining et al., 1998). This suggests that the regulation of the NFκB pathway in an 603 
immortalized cell line and in primary macrophages seems to be different.  604 
NFκB activation by IFNβ in chicken macrophages is partially dependent on the p38 MAPK, 605 
PI3K/Akt and/or TBK1/IKKε signalling pathways. To our knowledge, this is the first time 606 
that such a mechanism of action has been described for a type I IFN in chickens. Since 607 
pharmacological inhibition of these pathways did not completely abrogate NFκB activation in 608 
the HD11 cell line, other pathways involved in this activation remain to be identified. In 609 
addition, IFNβ induced the expression of IRF7 and could therefore potentially activate this 610 
transcription factor. Since both NFκB and IRF7 may bind to specific binding motifs present in 611 
the IFNβ promoter (Sick et al., 1998), we assume that IFNβ might be able to enhance its own 612 
expression through an amplification loop involving the aforementioned signalling pathways. 613 
Bacterial LPS activates Toll-like receptor 4 (TLR4) and triggers intracellular signalling 614 
pathways leading to NFκB activation via Myd88-dependent or the Myd88-independent 615 
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TRIF/TRAM-dependent pathways in mammals (Takeda and Akira, 2007). It is well 616 
established in mammals that the TRIF/TRAM-dependent pathway also activates IRF3, which 617 
results in IFNβ induction (Kawai and Akira, 2010). Previous studies have demonstrated that 618 
LPS-induced IFNβ is crucial for LPS-dependent NO production (Vadiveloo et al., 2000), pro-619 
inflammatory cytokine and chemokine expression (Thomas et al., 2006), and LPS-derived 620 
ISGs expression (Sheikh et al., 2014) in murine macrophages. In chickens, little is known 621 
regarding the contribution of IFNβ to LPS-induced inflammatory responses. Moreover, an 622 
orthologue of the Ticam2 gene (encoding TRAM) appears to be missing from the chicken 623 
genome, suggesting that TLR4 signalling through TRIF/TRAM might not be functional or 624 
ineffective in LPS-stimulated chicken cells (Keestra and van Putten, 2008). Nevertheless, our 625 
findings demonstrated that E. coli LPS or APEC are able to induce IFNβ production in 626 
chicken macrophages, corroborating previous data obtained with the MQ-NCSU chicken 627 
macrophage cell line (Barjesteh et al., 2014).  628 
Although all the molecular events involved in IFNα-induced macrophage reprogramming 629 
could not be identified, we demonstrated that the IFNα-activated STAT1 and p38 MAPK 630 
signalling pathways are likely to play a role in rendering macrophages more prone to mount 631 
an inflammatory response (via IFNβ production) after bacterial challenge. Based on our data, 632 
we assume that the cross-talk between signalling pathways downstream of TLR4 (e.g. NFκB, 633 
p38 MAPK and IRF7) and IFNAR leads to the potentiated production of IFNβ, which in turn 634 
activates NFκB via p38 MAPK, PI3K/Akt, TBK1/IKKε, and eventually other unidentified 635 
pathways, ultimately resulting in the potentiated production of pro-inflammatory mediators.  636 
Previous studies demonstrated that IFNα stimulation increases mouse peritoneal macrophage 637 
phagocytosis and bacterial adhesion through potential modifications of membrane surface 638 
receptors such as Fc or C3b receptors (Rollag et al., 1984). In the present study, we observed 639 
that bacterial adhesion remained unchanged upon IFNα stimulation. Therefore, we surmise 640 
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that specific and non-specific bacterial receptors (e.g. scavenger receptors) may not account 641 
for the enhancement in macrophage phagocytosis. In addition, Fc receptors do not appear to 642 
be involved in this phenomenon since neither bacteria nor bio-particles were opsonized. We 643 
thus assume that IFNα stimulation is able to induce unrecognized metabolic modifications 644 
within chicken macrophages that led to an increased phagocytic activity. This mechanism is 645 
likely to be IFNβ-independent since IFNβ-antiserum treatment did not reduce phagocytic 646 
activity of IFNα-primed macrophages (data not shown). 647 
A recent study demonstrated that a preceding LPAIV H9N2 infection increased innate 648 
immunity-related gene expression in response to LPS challenge in the HD11 cell line (Qi et 649 
al., 2016). Here we showed that a type I IFN enriched environment, likely to be present in 650 
mucosal surfaces (respiratory and intestinal tract) infected with LPAIV, was sufficient to 651 
reproduce this phenomenon in chicken macrophages. However, in the LPAIV infection-LPS 652 
challenge system, IFNA and TLR4 expression was found to be upregulated, a phenomenon 653 
that was not observed in the present work, suggesting that these responses could be type I 654 
IFN-independent. It would be challenging to test whether this pro-inflammatory response 655 
might also occur in vivo in an LPAIV-APEC superinfection model. Yet, previous studies 656 
indicated that LPAIV infection may pave the way for clinical colibacillosis in poultry (Bano 657 
et al., 2003; Mosleh et al., 2017; Umar et al., 2018). Even though type I IFNs are produced 658 
during viral infections, including low pathogenic avian influenza, the pathogenesis of 659 
viral/bacterial co-infections may be very different depending on the viral pathogen or strain. 660 
For example, during infectious bronchitis virus (IBV) infection, the type I IFN response 661 
remained unchanged between co-infected and E. coli infected groups, suggesting that a type I 662 
IFN response was not involved in the exacerbation of colibacillosis (Ariaans et al., 2008).  663 
Altogether, our data provide the first evidence for the role of type I IFNs in modifying 664 
chicken macrophage homeostasis, which may translate into a prominent pro-inflammatory 665 
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phenotype mediated by IFNβ when these cells encounter bacteria. Our findings point to an 666 
eminent role of this mechanism in the pathogenesis of viral/bacterial co-infections in the 667 
chicken that warrants further investigation by an in-depth analysis of the innate immune 668 
response in experimentally (co-)infected animals.  669 
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 876 
Figure Legends 877 
Figure 1. IFNα and IFNβ elicit different responses in chicken primary macrophages. 878 
chBMDM were stimulated with IFNα (50 ng/ml) or IFNβ (50 ng/ml) for 6h before qRT-PCR 879 
analysis. (A) OAS/OAS1, Mx/MX1, PKR/EIF2AK2, STAT1/STAT1 and IRF7/IRF7 gene 880 
expression. (B) IL-1β/IL1B, IFNβ/IFNB, IL-6/IL6, CXCLi2/IL8L2 gene expression. qRT-881 
PCR data are expressed as relative normalized expression (as compared to mock control 882 
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group). Values are ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001 or ****P < 0.0001 when 883 
compared to mock control group. #P < 0.05, ##P < 0.01, ###P < 0.001 or ####P < 0.0001 884 
when compared to IFNα group. Data are representative of two independent experiments 885 
performed in triplicates. 886 
 887 
Figure 2. IFNα and IFNβ differently modulate chicken primary macrophages signalling 888 
pathways. (A) chBMDM were stimulated with IFNα (50 ng/ml) or IFNβ (50 ng/ml) for 30 889 
min, 1h, 2h, 6h or 24h, then western blot analysis was performed on cell lysates. 890 
Representative immunoblotting revelations of STAT1, pSTAT1, p38, ppP38, p44/42, 891 
pp44/42, Akt, pAkt and pIκBα are shown. Protein molecular weight is indicated with black 892 
arrows. GAPDH was used as loading control. (B) HD11-NFκB reporter cells were incubated 893 
with IFNα (50 ng/ml), LPS (10 ng/ml) or IFNβ (50 ng/ml) alone or in combination with 894 
pharmacological inhibitors (SB-203580 at 10 µM, Wortmannin at 2 µM, BX795 at 2 µM and 895 
BAY11-7082 at 10 µM) for 6h then luciferase activity was measured. Data are expressed as 896 
fold increase in NFκB activity, as compared to control groups, and values are ± SEM. **P < 897 
0.01, ***P < 0.001 or ****P < 0.0001 when compared to mock control group. #P < 0.05, ##P 898 
< 0.01, ###P < 0.001 or ####P < 0.0001 when compared to the IFNα group (left graph) or the 899 
IFNβ group (right graph). Data are representative of two (A) or three (B) independent 900 
experiments performed in triplicates. 901 
 902 
Figure 3. IFNα elicits similar response patterns in a chicken macrophage cell line and in 903 
lung macrophages. HD11 cells (A, B, and C) or macrophages from chicken lungs (D) were 904 
stimulated with IFNα (50 ng/ml) for 6h before qRT-PCR analysis, nitric oxide (NO) dosage 905 
or flow cytometry analysis for cell viability. (A) PKR/EIF2AK2, Mx/MX1, OAS/OAS1, 906 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
IRF7/IRF7 and STAT1/STAT1 gene expression, (B) IL-1β/IL1B, IFNα/IFNA, IFNβ/IFNB, 907 
iNOS/NOS2 gene expression (left Y axis) and NO production (right Y axis). (C) 908 
Representative dot plot of HD11 double positive population for Annexin V and 7AAD, 909 
canonical markers of cell death, and histogram showing the percentage of double positive 910 
populations as compared to mock control group. (D) PKR/EIF2AK2, Mx/MX1, OAS/OAS1, 911 
IRF7/IRF7 and STAT1/STAT1 gene expression. Values are ± SEM. qRT-PCR data are 912 
expressed as relative normalized expression (as compared to mock control group). *P < 0.05, 913 
**P < 0.01, ***P < 0.001 or ****P < 0.0001 when compared to mock control group. Data are 914 
representative of two (C and D) or three (A and B) independent experiments performed in 915 
duplicates (A, B and C) or triplicates (D). 916 
 917 
Figure 4. IFNα priming potentiates the pro-inflammatory response to E. coli LPS in 918 
chicken macrophages. (A) Experimental protocol: HD11 cells were primed with IFNα (50 919 
ng/ml) or mock treatments for 16h. The medium was removed and cells were washed before 920 
receiving LPS (10 ng/ml), IFNα (50 ng/ml) or mock stimulation for 6h. (B) IL-1β/IL1B, 921 
iNOS/NOS2, IFNα/IFNA, IFNβ/IFNB gene expression and NO production. qRT-PCR data are 922 
expressed as relative normalized expression (as compared to mock control group). (C) 923 
Reactive Oxygen Species (ROS) production measured by flow cytometry using a fluorescent 924 
probe. Data are expressed as Mean Fluorescent Intensity (MFI). All values are ± SEM. ***P 925 
< 0.001 or ****P < 0.0001 when compared to mock control group. ###P < 0.001 or ####P < 926 
0.0001 when compared to LPS group. Data are representative of four (B) or two (C) 927 
independent experiments performed in triplicates. 928 
 929 
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Figure 5. IFNα priming boosts MHC class II expression and IFNβ production in 930 
response to E. coli LPS stimulation without exerting any measurable cytotoxic effect on 931 
chicken macrophages. (A) IFNβ production was quantified in HD11 supernatants through a 932 
bioassay using a CEC32-Mx luciferase reporter cell-line. Data are expressed as fold increase 933 
in IFNβ activity as compared to control groups. (B) Cell viability was assessed by flow 934 
cytometry using 7-AAD. Data are expressed as the percentage of dead cells (7AAD positive). 935 
(C) CD40 or MHC class II expression was analysed by flow cytometry. Data are expressed as 936 
Mean Fluorescence Intensity (MFI) from FITC+ cells. All values are ± SEM. *P < 0.05, **P < 937 
0.01, ***P < 0.001 or ****P < 0.0001 when compared to mock control group. ####P < 938 
0.0001 when compared to LPS group. Data are representative of two independent experiments 939 
performed in triplicates. 940 
 941 
Figure 6. IFNβ mediates the increased pro-inflammatory response to E. coli LPS in 942 
chicken macrophages following IFNα priming. HD11 cells (A and B) or chBMDM (C) 943 
were primed with IFNα (50 ng/ml) or mock treatments for 16h, then stimulated for 6h with 944 
LPS (10 ng/ml) and/or IFNβ-antiserum (17.5 µg/ml), and/or IFNβ (50 ng/ml) or IFNα (50 945 
ng/ml). IL-1β/IL1B, IFNβ/IFNB, iNOS/NOS2 gene expression and NO production in HD11 946 
(A) and in chBMDM (C). qRT-PCR data are expressed as relative normalized expression (as 947 
compared to mock control group). (B) Cell viability was assessed by flow cytometry using 7-948 
AAD. Data are expressed as the percentage of dead cells (7AAD positive). Values are ± SEM. 949 
*P < 0.05, **P < 0.01 or ****P < 0.0001 when compared to mock control group. #P < 0.05 or 950 
####P < 0.0001 when compared to LPS group. Data are representative of two (B and C) or 951 
three (A) independent experiments performed in duplicates. 952 
 953 
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Figure 7. IFNα priming potentiates the chicken macrophage pro-inflammatory response 954 
to APEC infection paralleled by an increased phagocytosis capacity. HD11 cells (A, B, C, 955 
D and E) or chicken lung macrophages (F and G) were primed with IFNα (50 ng/ml) or mock 956 
treatments for 16h, then cells were infected with 10 MOI of APEC BEN2908 or BEN2908 957 
GFP respectively, for 1h (adhesion assessment). Next, cells were treated with gentamycin to 958 
kill extracellular bacteria for 1h 30 min (intracellular bacterial load assessment) and incubated 959 
for up to 6h (for transcriptomic analysis). (A) IL-1β/IL1B and IFNβ/IFNB gene expression, as 960 
assessed by qRT-PCR, and NO and IFNβ production as assessed through nitrite dosage and 961 
CEC32-Mx bioassay, respectively. The number of adhered bacteria (B) and intracellular 962 
bacteria (C and F) was evaluated through colony-forming units (CFU) counts. Endocytosis 963 
(D) and phagocytosis (E) capacities were evaluated by flow cytometry. Cells were pre-treated 964 
with IFNα (50 ng/ml) or mock treatments for 16h, and incubated for 30 min with pHrodo™ 965 
Green dextran (endocytosis) or for 1h with pHrodo™ Green E. coli BioParticles® Conjugate 966 
(phagocytosis) at 50 µg/ml and 333µg/ml, respectively. Data are expressed as the percentage 967 
of pHrodo Green+ cells. (G) The fluorescence from intracellular GFP-expressing bacteria was 968 
evaluated by flow cytometry and is expressed as Mean Fluorescence Intensity (MFI) from 969 
GFP+ cells. Values are ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001 or ****P < 0.0001 when 970 
compared to mock control group. ####P < 0.0001 when compared to APEC group. Data are 971 
representative of two (F and G) or three (A, B, C, D and E) independent experiments 972 
performed in triplicates. 973 
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Target genes Forward primers 5’-3’ Reverse primers 5’-3’ 
B2M (β2M) CGTCCTCAACTGCTTCGCG TCTCGTGCTCCACCTTGC    
HPRT (HPRT) TGGTGGGGATGACCTCTCAA GGCCGATATCCCACACTTCG 
GAPDH (GAPDH) GTCCTCTCTGGCAAAGTCCAAG CCACAACATACTCAGCACCTGC 
EIF2AK2 (PKR) GGGACATGATTGAGCCAAAGCAAGA GAGCGTGGGGGTCTCCGGTA 
MX1 (Mx) ACGTCCCAGACCTGACACTA TTTAGTGAGGACCCCAAGCG 
OAS1 (OAS) CTTCGGAGTCAGCATCACCA TCCTGAATCACCTGCCCCAG 
IRF7 (IRF7) TGCCTCAGGCGTCCCCAATG TGTGTGCCCACAGGGTTGGC 
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Table 1. Primer pairs used in the present study for qRT-PCR analysis 978 
 979 
STAT1 (STAT1) AAGCAAACGTAATCTTCAGGATAAC TTTCTCTCCTCTTTCAGACAGTTG 
IL1B (IL1β) AGGCTCAACATTGCGCTGTA CTTGTAGCCCTTGATGCCCA 
IFNA (IFNα) CAACGACACCATCCTGGACA GGGCTGCTGAGGATTTTGAA 
IFNB (IFNβ) TCCTGCAACCATCTTCGTCA CACGTCTTGTTGTGGGCAAG 
NOS2 (iNOS) CCACCAGGAGATGTTGAACTATGTC CCAGATGTGTGTTTTCCATGCA 
IL6 (IL6) GCTTCGACGAGGAGAAATGC GCCAGGTGCTTTGTGCTGTA 
IL8L2 (CXCLi2) CTGCGGTGCCAGTGCATTAG AGCACACCTCTCTTCCATCC 
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Highlights: 
• Type I IFNs differently regulate intracellular events in chicken macrophages 
• IFNα priming boosts the macrophage inflammatory response to bacterial challenge 
• This boost in the inflammatory response is mediated by IFNβ 
• Bacterial uptake is increased if chicken macrophages are primed with IFNα 
 
